Table 3.
Uni and multivariate COX regression analysis of survival in women with breast cancer (n = 2,715)
| Univariate Analysis | Multivariate Analysis | |||||
| Age (y) | P-value | HR | 95% CI | P-value | HR | 95% CI |
| < 40 | 0.111 | 1.29 | 0.94–1.78 | 0.339 | 1.17 | 0.85–1.61 |
| 40 to 49 | 0.037 | 0.74 | 0.56–0.98 | 0.033 | 0.74 | 0.56–0.98 |
| 50 to 59 | - | 1.00 | - | - | 1.00 | - |
| 60 to 69 | 0.273 | 1.15 | 0.90–1.46 | 0.127 | 1.21 | 0.95–1.54 |
| 70 to 79 | < 0.001 | 2.02 | 1.59–2.56 | < 0.001 | 2.27 | 1.79–2.88 |
| ≥ 80 | < 0.001 | 4.09 | 3.20–5.22 | < 0.001 | 4.16 | 3.24–5.33 |
| Univariate Analysis | Multivariate Analysis | |||||
| Stage | P-value | HR | 95% CI | P-value | HR | 95% CI |
| Stage 0 | 0.049 | 0.61 | 0.37–0.99 | 0.101 | 0.66 | 0.41–1.08 |
| Stage I | - | 1.00 | - | - | 1.00 | - |
| Stage II | 0.057 | 1.39 | 0.99–1.96 | 0.016 | 1.53 | 1.08–2.15 |
| Stage III | < 0.001 | 3.72 | 2.70–5.12 | < 0.001 | 4.05 | 2.94–5.59 |
| Stage IV | < 0.001 | 8.00 | 5.99–10.68 | < 0.001 | 8.57 | 6.41–11.45 |
| Unknown | < 0.001 | 2.29 | 1.69–3.10 | < 0.001 | 2.08 | 1.54–2.82 |
H.R. Hazard Ratio, 95% CI 95% Confidence Interval. Variables were selected by Stepwise Criteria